XML 37 R94.htm IDEA: XBRL DOCUMENT v3.20.1
ADDITIONAL FINANCIAL INFORMATION - FINANCIAL STATEMENTS SCHEDULE I - STATEMENTS OF CASH FLOWS (Details)
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2019
CNY (¥)
Dec. 31, 2018
CNY (¥)
Dec. 31, 2017
CNY (¥)
Operating activities:        
Net loss $ (72,083) ¥ (501,827) ¥ (382,041) ¥ (249,327)
Adjustments to reconcile net income to net cash used in operating activities:        
Other non-current liabilities (316) (2,199) 8,135  
Net cash used in operating activities (73,599) (512,382) (343,018) (204,372)
Investing activities:        
Purchase of long-term investments       (140)
Proceeds from sale or maturity of short-term investments 123,977 863,106 578,359 80,198
Net cash (used in) provided by investing activities 34,140 237,675 44,454 (36,125)
Financing activities:        
Proceeds from ordinary shareholders 1,627 11,328   25
Payments of share repurchase 3,302 22,991    
Proceeds from IPO, net of issuance cost     694,878  
Proceeds of preferred shareholders     277,819 49,475
Net cash provided by financing activities 15,655 108,987 972,697 49,500
Effect of exchange rate changes on cash and cash equivalents, and restricted cash 1,394 9,702 11,947 (14,848)
Net (decrease) increase in cash and cash equivalents, and restricted cash (22,410) (156,018) 686,080 (205,845)
Cash and cash equivalents, and restricted cash at the beginning of the year 122,632 853,740 167,660 373,505
Cash and cash equivalents, and restricted cash at the end of the year 100,222 697,722 853,740 167,660
Parent        
Operating activities:        
Net loss (71,764) (499,606) (380,091) (248,580)
Adjustments to reconcile net income to net cash used in operating activities:        
Share of loss of subsidiaries and VIEs 71,654 498,837 381,601 247,746
Other current liabilities 6 43 2,284  
Other non-current liabilities (316) (2,199) 8,135  
Investment income (713) (4,962) (2,591)  
Net cash used in operating activities (1,133) (7,887) 9,338 (834)
Investing activities:        
Purchase of long-term investments     (821,962)  
Payment for shareholder loan to subsidiaries (29,215) (203,388)    
Proceeds from sale or maturity of short-term investments 16,837 117,214 25,160  
Net cash (used in) provided by investing activities (12,378) (86,174) (796,802)  
Financing activities:        
Proceeds from ordinary shareholders 1,627 11,328   25
Payments of share repurchase (3,302) (22,991)    
Proceeds from IPO, net of issuance cost     694,878  
Proceeds of preferred shareholders     277,819  
Net cash provided by financing activities (1,675) (11,663) 972,697 25
Effect of exchange rate changes on cash and cash equivalents, and restricted cash 2,710 18,866 75,672 (147)
Net (decrease) increase in cash and cash equivalents, and restricted cash (12,476) (86,858) 260,905 (956)
Cash and cash equivalents, and restricted cash at the beginning of the year 37,757 262,859 1,954 2,910
Cash and cash equivalents, and restricted cash at the end of the year $ 25,281 ¥ 176,001 ¥ 262,859 ¥ 1,954